Streetbeat News

Analyst Ratings

LLY

Eli Lilly's shares were climbing during Friday's trading session. The stock has been under pressure due to macro uncertainties, not fundamental concerns, according to BofA Securities. Analyst Geoff Meacham reiterated a Buy rating on Eli Lilly, raising the price target from $600 to $700. Meacham highlighted the company's upcoming obesity drugs, including Mounjaro, as key value drivers. He also noted the company's potential for margin expansion and the early- and mid-stage pipeline as unappreciated parts of the story.

Portfolio Pulse from Priya Nigam

October 06, 2023 | 4:23 pm

APA

Roth MKM analyst Leo Mariani has reiterated a 'Buy' rating on APA (NASDAQ:APA) and maintained a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:22 pm

ZVRA

Roth MKM analyst Jonathan Aschoff has reiterated a 'Buy' rating on Zevra Therapeutics (NASDAQ:ZVRA) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:21 pm

VLO

Mizuho analyst Nitin Kumar has maintained a 'Buy' rating on Valero Energy (NYSE:VLO) but lowered the price target from $174 to $159.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:21 pm

BLCO

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Bausch & Lomb (NYSE:BLCO), but lowered the price target from $22 to $21.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:17 pm

AZO

ORLY

Oppenheimer analyst Brian Nagel has downgraded the ratings for O'Reilly Automotive (ORLY) and AutoZone (AZO) from Outperform to Perform, while also lowering the price targets for both companies. Nagel believes that the COVID-19 pandemic-related tailwinds for auto part retail could continue to fade, lowering prospects of sales and EPS upside. He also noted that ongoing and potentially intensifying labor strikes will impact auto production at leading manufacturers.

Portfolio Pulse from Priya Nigam

October 06, 2023 | 4:14 pm

MDB

SHG

Shinhan Financial Group's shares are trading higher following Tigress Financial's reiteration of MongoDB with a Buy rating and an increased price target from $490 to $495.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:13 pm

BMY

Truist Securities analyst Robyn Karnauskas has reiterated a 'Buy' rating on Bristol-Myers Squibb (NYSE:BMY) and maintained an $84 price target.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:12 pm

MRK

Truist Securities analyst Robyn Karnauskas has reiterated a 'Buy' rating on Merck & Co (NYSE:MRK) and maintained a price target of $122.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:10 pm

EWTX

OSTK

PXD

SMR

SRRK

STGW

TROO

Several US stocks recorded gains in Friday's session. Notably, TROOPS, Inc. (TROO) surged 14.9%, NuScale Power Corporation (SMR) jumped 13.3% after Standard Power chose its SMR technology for two projects, and Scholar Rock Holding Corporation (SRRK) climbed 11% after completing enrollment for a Phase 3 trial. Overstock.com (OSTK) gained 11.4% after a director bought 31,800 shares, and Edgewise Therapeutics (EWTX) rose 10.4% after starting enrollment for a pivotal study. Pioneer Natural Resources (PXD) gained 9.8% following a report of a potential acquisition by Exxon Mobil (XOM), and Stagwell Inc. (STGW) gained 9.7% after a Buy rating initiation and $8 price target announcement.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 4:10 pm